Industry
Miraculins Purchases VeraLight’s Noninvasive Diabetes Screening Technology
Miraculins has completed the purchase agreement with VeraLight to acquire all of the relevant assets, including intellectual property, licenses, and regulatory approvals, inventories, data, and marketing materials, relating to VeraLight’s SCOUT DS technology. More...
09 Jul 2013
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Electrolyte Analyzer
CBS-4000 (CBS-400)
In Other News
Coalition to Strengthen the Future of Molecular Diagnostics
Seventeen-Year Monopoly on BRCA Testing Ended
Siemens and Janssen Collaborate on Companion Diagnostic
Metabolite Profiling Technology Licensed to Evaluate Cancer Diagnostics
Life Technologies Buys Instruments Distributor in Korea
Ventana and Barco Alliance to Revolutionize Digital Pathology Viewing Experience
Analytik Jena to Develop Products for Sepsis Diagnostics
Doctor's Choices Influenced by Lab Test Cost
Thermo Fisher to Acquire Life Technologies for USD 13.6 Billion
Companies Join to Create Technology Leader in Molecular Diagnostics
Rockland Immunochemicals Acquires Epi-Plus Antibody Product Line
Clinical Diagnostics Virtual Conference Attracts Major Sponsors and Speakers
Clinical Test Panel Aids Diagnosis of Treatable Dementia
Venaxis Enters Commercial Development Agreements of Appendicitis Test
Samsung Extends its Medical Device Business in the European Market
Report Analyzes Trends in Laboratory Automation
Lab21 and IntegraGen Collaborate on Colorectal Cancer Diagnostic
More Than 19 Billion IVD Tests Performed in 2012
Personalized Healthcare Tests Provide Genetic Information on Each Patient
Alere Acquires Epocal for USD 166 Million
Hologic to Buy Gen-Probe for USD 3.72 Billion
Oxford Immunotec and Lophius Biosciences to Share Intellectual Property
Clinical Potential and Use of DNA Sequencing on the Increase
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
